Jnana Therapeutics

📍 Boston, United States🗓 Founded 2017👥 90 employees💰 Last funded Nov 2022
Biotechnology🌐 jnanatx.com
Website LinkedIn
Jnana Therapeutics is a clinical-stage biotechnology company leveraging its next-generation chemoproteomics RAPID platform to discover medicines for highly validated, challenging-to-drug targets to treat diseases with high unmet need. Jnana is focused on developing first- and best-in-class therapies to treat a wide range of diseases, including rare diseases and immune-mediated diseases. Jnana’s wholly owned lead program is a potential first-in-class oral approach, targeting an allosteric site on the phenylalanine transporter SLC6A19, for the treatment of phenylketonuria (PKU), a rare genetic metabolic disease. Located in Boston, Jnana brings together scientific leaders in small molecule drug discovery and development, a highly experienced management team and the backing of leading life science investors Bain Capital Life Sciences, RA Capital Management, Polaris Partners, Versant Ventures, Avalon Ventures, Pfizer Ventures and AbbVie Ventures. For more information, please visit www.jnanatx.com and follow us on Twitter and on LinkedIn.
3
Total investors
2
Early stage
1
Mid stage
0
Late stage
2017
Founded

Investors

3 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
3
Investor activity2017–2022 · investors recorded per year
201712019120221
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Jnana Therapeutics?
Jnana Therapeutics has 3 investors on record on gritt.io, including 2 early-stage backers, 1 mid-stage.
When did Jnana Therapeutics last raise funding?
The most recent investment in Jnana Therapeutics recorded on gritt.io was in November 2022.
When was Jnana Therapeutics founded?
Jnana Therapeutics was founded in 2017.
What industry is Jnana Therapeutics in?
Jnana Therapeutics operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is Jnana Therapeutics based?
Jnana Therapeutics is headquartered in Boston, United States.